Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Exclusion Criteria

• •Child in care.
• •Any contraindications to vaccination as stated in the Prescribing Information.
• •Acute, severe febrile illness at the time of enrollment. The presence of a minor infection, such as a cold, will not exclude the subject from the study.
• •Previous receipt of a measles, mumps, rubella and/or varicella-virus containing vaccine less than 3 months prior to study entry.
• •Previous enrolment in this trial.
• •Subjects with impaired immune function, including primary or secondary immunodeficiencies based on medical history.
• •History of hypersensitivity to any component of the vaccine.
• •History of hypersensitivity following previous administration of measles, mumps, rubella and/or varicella-virus containing vaccines.
• •Receipt of human gamma globulins or a blood transfusion within 3 months prior to study entry.
• •Hypersensitivity to latex.
• •Pregnant or lactating female.